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the CC BY-NC-ND license (http://creaAbstract Objective: We evaluated who would need further evaluations such as retrograde
pyelography (RP) and/or ureteroscopy to diagnose upper urinary tract urothelial cancers
(UUTUCs) when abnormal findings for the upper urinary tract (UUT) were detected by
enhanced computed tomography (CT).
Methods: We retrospectively analyzed 125 patients who underwent enhanced CT for various
reasons and had abnormal findings for the UUT. Patients whose tumors were suspected to be
of extraureteral origin were excluded. All patients received RP and/or ureteroscopy to eval-
uate the UUTUCs.
Results: The median age of the 125 patients was 70 years and gross hematuria (26.4%) was the
most frequently observed symptoms. RP, ureteroscopy and both were performed for 121, 59
and 55 patients, respectively. CT revealed tumor-like lesions in 58 patients and the other pa-
tients had non-tumor-like lesions. UUTUCs were found in 43 (34.4%) of the 125 patients. All of
them had tumor-like lesions on CT. In 58 patients who had tumor-like lesions on CT, univariate
and multivariate analyses revealed that tumor diameter and tumor enhancement were signif-
icant predictive factors for UUTUCs. ROC curve analysis of enhanced CT to diagnose UUTUCs
revealed that a tumor diameter of 18 mm was the best cutoff point. The sensitivity, specificity
and accuracy were 90.0%, 98.8% and 92.7% for RP and 95.5%, 100% and 97.1% for ureteroscopy,
respectively. Both of them had high sensitivity, specificity and accuracy..ac.jp (A. Takayanagi).
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Who needs retrograde pyelography and ureteroscopy 45Conclusion: We should decide to evaluate the UUT according to the tumor diameter on
enhanced CT. When we evaluate the UUT in patients with tumor diameters of less than
20 mm, ureteroscopy is recommended.
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licenses/by-nc-nd/4.0/).1. Introduction
Upper urinary tract urothelial cancers (UUTUCs) are rare,
accounting for approximately 5%e10% of all urothelial
carcinomas [1]. We conventionally perform retrograde
pyelography (RP) and/or ureteroscopy for diagnosis when
UUTUC is suspected based on computed tomography (CT),
intravenous urography and so on.
Recently, thanks to the development of high resolution
CT, diagnostic accuracy has improved not only for urologi-
cal cancers, but also for other malignancies [2e5]. We can
diagnose some cases as UUTUCs by CT findings alone [6],
although other cases may require RP and/or ureteroscopy
to determine whether the abnormal lesion detected by CT
or another modality is UUTUC or not. Unfortunately, we do
not know which patients with abnormal lesions found by CT
need further evaluation including RP and/or ureteroscopy
for diagnosis of UUTUCs. In this study, we retrospectively
analyzed patients who had abnormal findings detected by
enhanced CT and subsequently underwent RP and/or ure-
teroscopy, and evaluated who needs such further invasive
evaluations to diagnose UUTUCs.
2. Materials and methods
2.1. Patients
We retrospectively analyzed 125 patients who underwent
enhanced CT for various reasons and had abnormal UUT
findings between January 2006 and December 2010.
Abnormal UUT findings included tumor-like lesions in the
UUT, hydronephrosis and hydroureter. These patients
received further evaluation, including RP and/or uretero-
scopy to evaluate the UUT. Enhanced CT in the early phase
was basically performed for these patients using a 64-mul-
tidetector row scanner (Toshiba Medical Systems, Tokyo,
Japan). We excluded patients whose tumors were suspected
to be of extraureteral origin. One of the two chief physicians
(AT and YT) made the final decision to perform RP, uretero-
scopy or both of them. Tumor enhancement was defined as a
change of the CT value of 10 HU or more. This study was
approved by the ethic committee of Hakodate Goryoukaku
Hospital (#H2801).
2.2. Methods of retrograde pyelography
RP was performed under anesthesia for males but without it
for females. A 6 Fr open-ended catheter was inserted into
the ureteral orifice using cystoscopy. Then contrast medium
could be introduced directly into the upper collectingsystem and the ureters [7]. We also obtained urine from the
catheter for urine cytology.
2.3. Methods of ureteroscopy
Ureteroscopy was performed under anesthesia for all pa-
tients. A semi-rigid ureteroscope (6.9 Fr, MR-6LA, Olympus,
USA) was inserted through the ureteral orifice and we
examined the entire ureter [8]. We have used a flexible
ureteroscope (5.3 Fr, URF-P5, Olympus, Japan) in our hos-
pital since 2008. Patients underwent both semi-rigid and
flexible ureteroscopy from 2008 or later if a tumor above
the ureteropelvic junction was suspected.
2.4. Follow-up of patients
All patients who were diagnosed with UUTUCs had received
radical treatment or systemic therapy according to the
clinical stage of the UUTUC. Patients who were diagnosed
as not having UUTUC were generally followed up in our
department every 3 months for at least 1 year. During
follow-up UUTUCs were not detected in any of these
patients.
2.5. Statistical analysis
Statistical analyses were performed with EZR (Saitama
Medical Center, Jichi Medical University, Japan), which is a
graphical user interface for R (The R Foundation for Sta-
tistical Computing). More precisely, it is a modified version
of R commander designed to add statistical functions
frequently used in biostatics [9]. p < 0.05 was considered to
be significant. Univariate analysis was performed using the
ManneWhitney U test, chi-square test and log-rank test.
Multivariate analysis was performed using Logistic regres-
sion analysis. We performed receiver operating character-
istic (ROC) curve analysis to evaluate the diagnostic ability
of enhanced CT and calculated the area under the curve
(AUC). To determine the cutoff value for diagnosis, we used
Youden’s Index (sensitivity þ specificity  1) [10].
3. Results
3.1. Patients’ characteristics
A total of 125 patients were eligible for this study. The
median age of the patients was 70 years (Table 1). Gross
hematuria was found in 33 patients (26.4%) and was the
most frequently observed symptom. Fifty-seven (45.6%)
patients were referred from other hospitals because of
Table 1 Patients’ characteristics.
Variable Value
Number of patients, n 125
Age, median (range) 70 (36e86)
Reasons for CT, n (%)
Hematuria 39 (31.2)
Gross hematuria 33 (26.4)
Microscopic hematuria 6 (4.8)
Back pain 15 (12.0)
Follow-up of bladder cancer 11 (8.8)
Decrease of renal function 5 (4.0)
Uncertain 55 (44.0)
CT findings, n (%)
With tumor-like lesion 58 (46.4)
Without tumor-like lesion 67 (53.6)




Not performed 18 (14.4)
Methods of UUTUC evaluation, n (%)
RP only 66 (52.8)
Ureteroscopy and RP 55 (44.0)
Ureteroscopy only 4 (3.2)
CT, computed tomography; UUTUC, upper urinary tract uro-
thelial cancer; RP, retrograde pyelography.
Figure 1 The relationship between the CT findings and the
final diagnosis. UUTUC, upper urinary tract urothelial cancer.
46 A. Takayanagi et al.abnormal UUT findings. Most of them underwent CTwithout
having urinary tract symptoms and the details of why they
did so were not clear. Although 58 patients had tumor-like
lesions on CT, 67 exhibited hydronephrosis or hydroureter
without a tumor-like lesion. RP, ureteroscopy and both
were performed in 121, 59 and 55 patients, respectively.
Sixteen patients underwent semi-rigid ureteroscopy before
2008, and the other 43 flexible ureteroscopy from 2008 or
later.
3.2. Results of UUT evaluation
UUTUCs were found in 43 (34.4%) of the 125 patients,
ureteral stricture in 35 (28.0%), ureteropelvic junction
obstruction in 18 (14.4%) and there were no abnormal
findings in 29 (23.2%). Of the 58 patients with tumor-like
lesions revealed by CT, 43 (74.1%) were finally diagnosed
with UUTUCs. On the other hand, none of the 67 patients
who did not show tumor-like lesions on CT were finally
diagnosed with UUTUCs. Therefore the diagnostic accuracy
of enhanced CT for UUTUCs was 88.0%.
3.3. Relationship between the CT findings and final
diagnosis
We focused on the 58 patients with tumor-like lesions
revealed by CT and evaluated the relationship between the
tumor diameter in the axial plane and the final diagnosis
(Fig. 1). All 15 patients who had tumors with a diameter of
20mmormorewere finally diagnosedwith UUTUCs. Of the 43
patients who had tumors with a diameter of less than 20 mm,
28 (65.1%) patients were finally diagnosed with UUTUCs.We performed statistical analysis of these 58 patients
with tumor-like lesions revealed by CT to identify the
predictive factors for UUTUCs using the following four
factors: tumor diameter, the existence of hydronephrosis,
enhancement of the tumor and tumor location. In univari-
ate analysis, tumor diameter and tumor enhancement were
significant predictive factors for UUTUCs (p Z 0.02,
p Z 0.004) (Table 2). In multivariate analysis, tumor
diameter and tumor enhancement remained significant (HR
Z 1.23, p Z 0.01; HR Z 6.78, p Z 0.02, respectively).
We performed ROC curve analysis evaluating the diag-
nostic ability of enhanced CT using the tumor diameter
(Fig. 2). The AUC was 0.783 and the 95% confidence interval
(95%CI) ranged from 0.641 to 0.925. The best cutoff point
according to Youden’s Index was 18 mm and the sensitivity
and specificity were 90.7% and 53.3%, respectively.
3.4. Results of retrograde pyelography
Of the 121 patients who underwent RP, 36 (29.8%) were
finally diagnosed with UUTUCs. False negative results were
found in four (3.3%) patients and a false positive result in
one (0.8%). Three of the four patients with false negatives
underwent ureteroscopy and UUTUCs were detected.
Although the other patient underwent semi-rigid uretero-
scopy, UUTUC was not detected. Because his urine cytology
obtained during ureteroscopy was positive, he was finally
judged as having UUTUC based on the positive urine
cytology. Thereafter he underwent radical nephroureter-
ectomy and pathological examination confirmed UUTUC in
his renal pelvis. The patient with the false positive result
underwent ureteroscopy and was diagnosed as having
multiple ureteral polyps. The sensitivity, specificity, and
accuracy of RP in the 121 patients were 90.0%, 98.8%, and
95.9%, respectively (Table 3). On the other hand, in 58 of
the 121 patients with tumor-like lesions on CT, the accuracy
of RP was 92.7% (Table 4).
3.5. Results of ureteroscopy
Of the 59 patients who underwent ureteroscopy, 21 (35.6%)
were finally diagnosed with UUTUCs. Although a false
Table 2 Univariate and multivariate analyses for risk factors to predict UUTUC in 58 patients.
Risk factors Univariate analysis Multivariate analysis
HR 95% CI p-Value HR 95% CI p-Value
Tumor diameter 1.20 1.03e1.39 0.02 1.23 1.05e1.44 0.01
Tumor enhancement 7.05 1.86e26.69 0.004 6.78 1.33e34.45 0.02
Hydronephrosis 1.72 0.50e5.89 0.39 0.79 0.15e4.11 0.78
Renal pelvic cancer 1.07 0.31e3.72 0.91 0.25 0.04e1.43 0.12
UUTUC, upper urinary tract urothelial cancer; HR, hazard ratio; 95% CI, 95% confidence interval.
Figure 2 ROC curve analysis to evaluate the diagnostic
ability of enhanced CT. ROC, receiver operating characteristic;
CT, computed tomography.
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no false positive result. The renal pelvic cancer of this
patient, who was described in the “results of RP”, was
missed because we could use only a semi-rigid ureteroscope
at that time. There were no severe adverse events due to
RP or ureteroscopy in any case. The sensitivity, specificity,
and accuracy of ureteroscopy in the 59 patients were
95.5%, 100%, and 98.3%, respectively (Table 3). On the
other hand, in the 58 patients with tumor-like lesions
revealed by CT, the accuracy of ureteroscopy was 97.1%
(Table 4).
4. Discussion
Enhanced CT is widely performed to examine the UUT. In
this study we focused on 125 patients who showed
abnormal findings in the UUT by enhanced CT. Our resultsTable 3 Diagnostic accuracy of RP and ureteroscopy for
UUTUC in all 125 patients (%).
RP (n Z 121) Ureteroscopy (n Z 59)
Sensitivity 90.0 (36/40) 95.5 (21/22)
Specificity 98.8 (80/81) 100 (37/37)
PPV 97.3 (36/37) 100 (21/21)
NPV 95.2 (80/84) 97.4 (37/38)
Accuracy 95.9 (116/121) 98.3 (58/59)
RP, retrograde pyelography; UUTUC, upper urinary tract uro-
thelial cancer; PPV, positive predictive value; NPV, negative
predictive value.showed that the diagnostic accuracy of enhanced CT was as
high as 88.0%. Therefore contrast CT is assumed to be very
useful to examine the UUT. Caoili et al. [11] and Mahesh-
wari et al. [12] also reported that CT was useful to examine
the UUT, and its sensitivity was 89%e100%.
In our study, 74.1% of the patients with tumor-like le-
sions found by enhanced CT were finally diagnosed with
UUTUCs. According to the results of ROC curve analysis, a
tumor diameter of 18 mm was the best cutoff point to
detect UUTUCs. However, 9.3% of the patients were false
negative, and 18 mm is a little complicated to use in the
clinical setting. To reduce the false negative rate and
enhance the power of UUTUC screening by CT, we believe
20 mm was the best cutoff point. Although we had a limited
number of patients, all the patients with tumor diameters
of 20 mm or more had UUTUCs.
In this study, we had false-negative findings in three
examined by RP (diagnostic accuracy: 92.5%) and one pa-
tient examined by ureteroscopy (diagnostic accuracy:
96.7%). The one false-negative patient examined by semi-
rigid ureteroscopy had renal pelvic cancer. At that time we
could not use a flexible ureteroscope. Had flexible ure-
teroscopy been possible, we might have been able to
detect the tumor. Both RP and ureteroscopy had high
sensitivity and specificity to evaluated the UUTUCs. Since
ureteroscopy, especially the flexible type, might be
consider desirable to evaluate UUT. It had higher accuracy
to diagnose UUTUCs compared to RP, unfortunately there
was no statistical difference (p Z 0.665), since there may
be patient’s selection bias (discussed below).
Based on our results, we propose an algorithm to eval-
uate the UUT (Fig. 3). To examine the UUT, it is desirable to
perform enhanced CT. If tumor-like lesions are detected byTable 4 Diagnostic accuracy of RP and ureteroscopy for
UUTUC in 58 patients who had tumor-like lesions revealed
by CT (%).
RP (n Z 55) Ureteroscopy (n Z 34)
Sensitivity 91.1 (41/45) 95.7 (22/23)
Specificity 100 (10/10) 100 (11/11)
PPV 100 (41/41) 100 (22/22)
NPV 71.4 (10/14) 91.7 (11/12)
Accuracy 92.7 (51/55) 97.1 (33/34)
RP, retrograde pyelography; UUTUC, upper urinary tract uro-
thelial cancer; CT, computed tomography; PPV, positive pre-
dictive value; NPV, negative predictive value.
Figure 3 The strategy to evaluate the UUT to detect UUTUC.
UUT, upper urinary tract; CT, computed tomography; RP,
retrograde pyelography; UUTUC, upper urinary tract urothelial
cancer.
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according to the tumor diameter. If it is 20 mm or greater in
addition to tumor enhancement, we can judge the tumor to
be UUTUC. On the other hand, if the tumor diameter is less
than 20 mm, we should perform further ureteroscopic
evaluation of the UUT. Otherwise, if tumor-like lesion were
not detected by CT, we may not need to recommend per-
forming ureteroscopy aggressively. This algorithm does not
include voided urine cytology because of its low sensitivity.
However, since the specificity of urine cytology is very high,
further evaluation including ureteroscopy may not be
needed in patients with tumor-like lesions detected by CT
and positive voided urine cytology [13]. Further study with
a large population will be needed to confirm this algorithm.
Our study had several limitations. First, this study is
retrospective. Second, we only included the patients who
underwent examination of the UUT. Therefore patients who
were judged to have UUTUCs only by CT findings but who
did not undergo further examination of the UUT were not
included in this study. Third, not all patients underwent RP
and ureteroscopy because the method of evaluation was
decided by the physician-in-chief. Therefore there is a
possibility of patient selection bias. Some included patients
received only semi-rigid ureteroscopy and not flexible
ureteroscopy because they were seen before the intro-
duction of flexible ureteroscopy. The diagnostic accuracy of
ureteroscopy for tumors in the renal pelvis is likely to have
improved after the introduction of flexible ureteroscopy
compared with that of only semi-rigid ureteroscopy. Thus
the diagnostic accuracy is recently estimated to be higher.
5. Conclusion
Enhanced CT is a suitable method for examining the UUT.
We can decide to evaluate the possibility of UUTUCsaccording to the tumor diameter on CT. When we do so
ureteroscopy is recommended.Conflicts of interest
The authors declare no conflict of interest.References
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